Chinese english Germany Korea

1,3-Dioxolane-4,5-dimethanol, α4,α4,α5,α5-tetrakis[4-methoxy-3,5-bis(1-methylethyl)phenyl]-2,2-dimethyl-, (4R,5R)-

化学構造式
2828439-65-0
CAS番号.
2828439-65-0
化学名:
别名:
英語名:
1,3-Dioxolane-4,5-dimethanol, α4,α4,α5,α5-tetrakis[4-methoxy-3,5-bis(1-methylethyl)phenyl]-2,2-dimethyl-, (4R,5R)-
英語别名:
((4R,5R)-2,2-Dimethyl-1,3-dioxolane-4,5-diyl)bis(bis(3,5-diisopropyl-4-methoxyphenyl)methanol);1,3-Dioxolane-4,5-dimethanol, α4,α4,α5,α5-tetrakis[4-methoxy-3,5-bis(1-methylethyl)phenyl]-2,2-dimethyl-, (4R,5R)-
CBNumber:
CB912248848
化学式:
C59H86O8
分子量:
923.33
MOL File:
2828439-65-0.mol

1,3-Dioxolane-4,5-dimethanol, α4,α4,α5,α5-tetrakis[4-methoxy-3,5-bis(1-methylethyl)phenyl]-2,2-dimethyl-, (4R,5R)- 物理性質

沸点 :
851.6±65.0 °C(Predicted)
比重(密度) :
1.042±0.06 g/cm3(Predicted)
酸解離定数(Pka):
12.39±0.29(Predicted)

安全性情報

1,3-Dioxolane-4,5-dimethanol, α4,α4,α5,α5-tetrakis[4-methoxy-3,5-bis(1-methylethyl)phenyl]-2,2-dimethyl-, (4R,5R)- 価格

メーカー 製品番号 製品説明 CAS番号 包装 価格 更新時間 購入

1,3-Dioxolane-4,5-dimethanol, α4,α4,α5,α5-tetrakis[4-methoxy-3,5-bis(1-methylethyl)phenyl]-2,2-dimethyl-, (4R,5R)- 化学特性,用途語,生産方法

1,3-Dioxolane-4,5-dimethanol, α4,α4,α5,α5-tetrakis[4-methoxy-3,5-bis(1-methylethyl)phenyl]-2,2-dimethyl-, (4R,5R)- 上流と下流の製品情報

原材料

準備製品

1,3-Dioxolane-4,5-dimethanol, α4,α4,α5,α5-tetrakis[4-methoxy-3,5-bis(1-methylethyl)phenyl]-2,2-dimethyl-, (4R,5R)- 生産企業

Global( 4)Suppliers
名前 電話番号 電子メール 国籍 製品カタログ 優位度
Shanghai Anyinuo Biomedical Technology Co., Ltd. 021-34625901
420970979@qq.com China 5872 58
Bide Pharmatech Ltd. 400-1647117 13681763483
 product02@bidepharm.com China 62163 58
Bide Pharmatech Ltd. 400-6005915
sales@picasso-e.com China 39665 58
Shanghai Jieshikai Biotechnology Co. , Ltd. 021-57520305 15221441005
 wangkang@jskchem.com China 49234 58
  • 2828439-65-0
  • ((4R,5R)-2,2-Dimethyl-1,3-dioxolane-4,5-diyl)bis(bis(3,5-diisopropyl-4-methoxyphenyl)methanol)
  • 1,3-Dioxolane-4,5-dimethanol, α4,α4,α5,α5-tetrakis[4-methoxy-3,5-bis(1-methylethyl)phenyl]-2,2-dimethyl-, (4R,5R)-
Copyright 2017 © ChemicalBook. All rights reserved